FitLife Brands Revenue Soars 47% on Irwin Acquisition, Net Income Dips

TL;DR

**FTLF's big bet on Irwin Naturals boosted revenue but crushed net income, making it a risky play until they prove integration and profitability.**

AI Summary

FitLife Brands, Inc. (FTLF) reported a significant increase in revenue for the three and nine months ended September 30, 2025, primarily driven by the acquisition of Irwin Naturals in August 2025. Revenue for the three months ended September 30, 2025, surged to $23.485 million from $15.977 million in the prior year, a 47% increase. For the nine months, revenue grew to $55.548 million from $49.456 million, an 12.3% increase. Despite the revenue growth, net income for the three months decreased to $0.921 million from $2.126 million, a 56.6% drop, and for the nine months, it fell to $4.686 million from $6.914 million, a 32.2% decline. This reduction in net income is largely attributable to a substantial increase in merger and acquisition related expenses, which rose to $0.820 million for the quarter and $1.848 million for the nine months, up from $0.059 million and $0.217 million respectively in the prior year periods. The company also saw a significant increase in total assets to $109.984 million as of September 30, 2025, from $58.531 million at December 31, 2024, largely due to the Irwin acquisition, which involved $42.500 million in cash consideration and new term loans of $29.750 million and a $6.000 million revolving line of credit. Inventories also more than doubled to $22.227 million from $11.074 million, and accounts receivable increased to $9.640 million from $1.626 million, reflecting the expanded operations.

Why It Matters

This filing reveals FitLife Brands' aggressive growth strategy through acquisition, specifically the $42.5 million Irwin Naturals deal. While revenue is up significantly, the sharp decline in net income and the substantial increase in debt to finance the acquisition raise questions about profitability and leverage. Investors should scrutinize how quickly FTLF can integrate Irwin and realize synergies to improve the bottom line, especially given the competitive landscape in the nutritional supplement market. Employees of both FitLife and Irwin will face integration challenges, and customers may see changes in product availability or branding. The broader market will watch to see if this acquisition-led growth model can deliver sustainable shareholder value.

Risk Assessment

Risk Level: high — The risk level is high due to the significant increase in debt and the decline in net income following the Irwin Naturals acquisition. Total liabilities more than doubled to $68.092 million as of September 30, 2025, from $22.405 million at December 31, 2024, largely driven by new term loans of $40.452 million and a $6.000 million revolving line of credit. Net income for the three months ended September 30, 2025, decreased by 56.6% to $0.921 million, indicating potential integration challenges or increased operating costs post-acquisition.

Analyst Insight

Investors should exercise caution and closely monitor FitLife Brands' upcoming earnings reports for signs of successful integration of Irwin Naturals and improved profitability. Consider holding off on new investments until there's clear evidence of synergy realization and a reversal in the net income trend, as the current financial picture suggests increased leverage and reduced short-term earnings power.

Financial Highlights

debt To Equity

1.62

revenue

$55.548M

total Assets

$109.984M

total Debt

$68.092M

net Income

$4.686M

gross Margin

39.46%

cash Position

$3.512M

revenue Growth

+12.3%

Key Numbers

• $23.485B — Revenue (3 months) (Increased 47% from $15.977B in Q3 2024)
• $55.548B — Revenue (9 months) (Increased 12.3% from $49.456B in 9M 2024)
• $0.921B — Net Income (3 months) (Decreased 56.6% from $2.126B in Q3 2024)
• $4.686B — Net Income (9 months) (Decreased 32.2% from $6.914B in 9M 2024)
• $109.984B — Total Assets (Increased 87.9% from $58.531B at Dec 31, 2024)
• $68.092B — Total Liabilities (Increased 203.0% from $22.405B at Dec 31, 2024)
• $1.848B — M&A Related Expenses (9 months) (Increased from $0.217B in 9M 2024)
• $40.452B — Borrowings on Term Loans (New borrowings for the 9 months ended Sep 30, 2025)
• 9,391,072 — Shares Outstanding (As of November 12, 2025)
• $22.227B — Inventories (Increased 100.7% from $11.074B at Dec 31, 2024)

Key Players & Entities

• Irwin Naturals (company) — acquired by FitLife Brands for $42.5 million
• First-Citizens Bank & Trust Company (company) — provided new term loan and revolving line of credit
• Amazon (company) — e-commerce platform for product distribution
• GNC (company) — franchised stores distributing NDS Products
• Nasdaq Capital Market (regulator) — exchange where FTLF common stock trades
• $42,500 (dollar_amount) — total consideration for Irwin acquisition
• $29,750 (dollar_amount) — funded from new term loan for Irwin acquisition
• $6,000 (dollar_amount) — funded from new revolving line of credit for Irwin acquisition
• $23,485 (dollar_amount) — revenue for three months ended September 30, 2025
• $0.921 (dollar_amount) — net income for three months ended September 30, 2025

FAQ

Risk Factors

• Increased Debt Load [high — financial]: The company's total liabilities have surged by 203.0% from $22.405 million at December 31, 2024, to $68.092 million as of September 30, 2025. This significant increase is largely due to new term loans of $29.750 million and a $6.000 million revolving line of credit used to finance the Irwin Naturals acquisition, increasing financial leverage and interest expense.
• Integration of Irwin Naturals [high — operational]: The acquisition of Irwin Naturals in August 2025 is a primary driver of revenue growth but also introduces significant integration risks. The company experienced a substantial increase in merger and acquisition related expenses, rising to $1.848 million for the nine months ended September 30, 2025, from $0.217 million in the prior year, indicating the complexity and cost associated with integrating the new business.
• Inventory Management [medium — operational]: Inventories have more than doubled to $22.227 million from $11.074 million at December 31, 2024. This substantial increase, driven by the expanded operations post-acquisition, heightens the risk of inventory obsolescence and carrying costs, requiring effective inventory management strategies.
• Accounts Receivable Management [medium — operational]: Accounts receivable have increased significantly to $9.640 million from $1.626 million at December 31, 2024. This growth, reflecting expanded operations, necessitates robust credit and collections processes to mitigate the risk of bad debt and ensure timely cash inflow.
• Decreased Profitability Despite Revenue Growth [high — financial]: While revenue increased by 47% for the three months ended September 30, 2025, net income decreased by 56.6% to $0.921 million from $2.126 million. For the nine months, net income fell 32.2% to $4.686 million despite a 12.3% revenue increase. This indicates pressure on margins, partly due to increased operating expenses, particularly M&A costs.
• Compliance with Acquisition Regulations [medium — regulatory]: The acquisition of Irwin Naturals may be subject to various regulatory reviews and approvals. Failure to comply with all applicable regulations related to mergers and acquisitions could lead to penalties or delays, impacting the integration and expected synergies.

Industry Context

FitLife Brands operates in the health and wellness sector, which is characterized by strong consumer demand for nutritional supplements and related products. The industry is competitive, with numerous players ranging from large established companies to smaller niche brands. Recent trends include a focus on natural and organic ingredients, personalized nutrition, and direct-to-consumer sales channels. The acquisition of Irwin Naturals positions FitLife to capitalize on these trends and expand its market reach.

Regulatory Implications

The company must ensure compliance with all relevant regulations pertaining to the sale of dietary supplements, including FDA guidelines on labeling, manufacturing, and marketing claims. Post-acquisition, integrating Irwin Naturals requires adherence to any specific regulatory requirements associated with its product lines and operations. Increased scrutiny on M&A activities could also pose regulatory challenges.

What Investors Should Do

1. Monitor integration progress of Irwin Naturals.
2. Analyze the impact of increased debt on future profitability.
3. Evaluate inventory and accounts receivable trends.
4. Assess the sustainability of revenue growth.

Key Dates

• 2025-08-01: Acquisition of Irwin Naturals — This strategic acquisition significantly boosted revenue and total assets, but also led to increased debt and M&A expenses.
• 2025-09-30: End of Q3 2025 — Reporting period for the 10-Q, showing substantial revenue growth driven by the acquisition, but a decline in net income due to integration costs.
• 2024-12-31: End of Fiscal Year 2024 — Baseline for comparison of assets, liabilities, and inventory levels before the major acquisition.

Glossary

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (The company's goodwill increased significantly to $19.366 million from $13.022 million, reflecting the premium paid for the Irwin Naturals acquisition.)

Intangibles, net of amortization

Represents the value of non-physical assets (like patents, trademarks, brand names) that have a finite useful life, net of accumulated amortization. (This line item increased substantially to $51.648 million from $26.235 million, largely due to the acquired intangible assets of Irwin Naturals.)

Right of use asset

An asset representing a lessee's right to use an underlying asset for the lease term, recognized under ASC 842 for leases. (This asset increased to $785 thousand from $412 thousand, reflecting the lease obligations of the acquired company.)

Derivative liability

A financial instrument whose value is derived from an underlying asset, index, or security, and which has a negative fair value for the reporting entity. (A new derivative liability of $32 thousand appeared on the balance sheet as of September 30, 2025, potentially related to financing or hedging activities.)

Merger and acquisition related

Expenses incurred directly in connection with the process of acquiring or merging with another company. (These expenses rose dramatically to $1.848 million for the nine months ended September 30, 2025, from $0.217 million in the prior year, highlighting the cost of the Irwin Naturals acquisition.)

Year-Over-Year Comparison

Compared to the prior year, FitLife Brands has experienced a significant transformation driven by the acquisition of Irwin Naturals. Revenue has seen substantial growth, with a 47% increase in the third quarter and 12.3% for the nine months. However, this growth has come at the cost of profitability, with net income declining by 56.6% and 32.2% respectively, largely due to a massive increase in M&A related expenses. Total assets have nearly doubled, reflecting the acquisition's scale, while total liabilities have more than tripled, indicating a significantly higher debt burden. New risks related to integration, increased debt servicing, and inventory management have emerged.

Key Financial Figures

• $0.01 — registered Common Stock, par value $0.01 per share FTLF The Nasdaq Capital M

Filing Documents

• ftlf20250930_10q.htm (10-Q) — 1234KB
• ex_885319.htm (EX-31.1) — 13KB
• ex_885320.htm (EX-31.2) — 13KB
• ex_885321.htm (EX-32.1) — 4KB
• ex_885322.htm (EX-32.2) — 4KB
• 0001437749-25-034607.txt ( ) — 6084KB
• ftlf-20250930.xsd (EX-101.SCH) — 44KB
• ftlf-20250930_def.xml (EX-101.DEF) — 404KB
• ftlf-20250930_lab.xml (EX-101.LAB) — 344KB
• ftlf-20250930_pre.xml (EX-101.PRE) — 426KB
• ftlf-20250930_cal.xml (EX-101.CAL) — 42KB
• ftlf20250930_10q_htm.xml (XML) — 810KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements Condensed Consolidated Balance Sheets (unaudited) 1 Condensed Consolidated Statements of Income and Comprehensive Income (unaudited) 2 Condensed Consolidated Statements of Stockholders' Equity (unaudited) 3 Condensed Consolidated Statements of Cash Flows (unaudited) 4 Notes to Condensed Consolidated Financial Statements (unaudited) 5 Item 2. Management's Discussion & Analysis of Financial Condition and Results of Operations 17 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 27 Item 4.

Controls and Procedures

Controls and Procedures 27

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 28 Item 1A.

Risk Factors

Risk Factors 28 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28 Item 3. Defaults Upon Senior Securities 28 Item 5. Other Information 28 Item 6. Exhibits 28 Special Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q ( " Quarterly Report " ), including " Management ' s Discussion and Analysis of Financial Condition and Results of Operations " in Item 2 of Part I of this Quarterly Report, includes forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as " may " , " should " , " expects " , " plans " , " anticipates " , " believes " , " estimates " , " predicts " , " potential " , " proposed " , " intended " , or " continue " or the negative of these terms or other comparable terminology. You should read statements that contain these words carefully, because they discuss our expectations about our future operating results or our future financial condition or state other " forward-looking " information. There may be events in the future that we are not able to accurately predict or control. Before you invest in our securities, you should be aware that the occurrence of any of the events described in this Quarterly Report could substantially harm our business, results of operations and financial condition, and that upon the occurrence of any of these events, the trading price of our securities could decline and you could lose all or part of your investment. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, growth rates, levels of activity, performance

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS FITLIFE BRANDS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except per share data) September 30, 2025 December 31, 2024 (Unaudited) ASSETS: CURRENT ASSETS Cash and cash equivalents $ 3,512 $ 4,468 Restricted cash - 52 Accounts receivable, net of allowance for credit losses of $ 22 and $ 41 , respectively 9,640 1,626 Inventories, net of allowance for obsolescence of $ 254 and $ 100 , respectively 22,227 11,074 Prepaid expense and other current assets 2,021 923 Total current assets 37,400 18,143 Property and equipment, net 135 75 Right of use asset 785 412 Intangibles, net of amortization of $ 275 and $ 152 , respectively 51,648 26,235 Goodwill 19,366 13,022 Deferred tax asset 567 - Other assets 83 644 TOTAL ASSETS $ 109,984 $ 58,531 LIABILITIES AND STOCKHOLDERS' EQUITY: CURRENT LIABILITIES: Accounts payable $ 9,148 $ 4,067 Accrued expense 6,803 684 Income taxes payable 1,688 1,415 Product returns 863 564 Term loan – current portion 8,094 4,500 Revolving line of credit 6,000 - Lease liability – current portion 429 81 Total current liabilities 33,025 11,311 Term loan, net of current portion and unamortized deferred finance costs 32,363 8,550 Long-term lease liability, net of current portion 385 331 Derivative liability 32 - Deferred tax liability 2,287 2,213 TOTAL LIABILITIES 68,092 22,405 STOCKHOLDERS' EQUITY: Preferred stock, $ 0.01 par value, 10,000 shares authorized, none outstanding as of September 30, 2025 and December 31, 2024 - - Common stock, $ 0.01 par value, 120,000 shares authorized; 9,391 and 9,210 issued and outstanding as of September 30, 2025 and December 31, 2024 94 92 Additional paid-in capital 32,141 31,129 Retained earnings 10,253 5,567 Accumulated other comprehensive loss ( 596 ) ( 662 ) TOTAL STOCKHOLDERS' EQUITY 41,892 36

View Full Filing

View this 10-Q filing on SEC EDGAR